PUBLICATION

Cannabinoid type-2 receptors modulate terpene induced anxiety-reduction in zebrafish

Authors
Johnson, A.L., Verbitsky, R., Hudson, J., Dean, R., Hamilton, T.J.
ID
ZDB-PUB-231023-52
Date
2023
Source
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie   168: 115760115760 (Journal)
Registered Authors
Hamilton, Trevor
Keywords
CB(2) receptors, Endocannabinoid system, anxiety, cannabis terpenes, open field test, zebrafish models
MeSH Terms
  • Animals
  • Anti-Anxiety Agents*/pharmacology
  • Anxiety/chemically induced
  • Anxiety/drug therapy
  • Cannabinoids*/pharmacology
  • Humans
  • Receptors, Cannabinoid
  • Rimonabant
  • Terpenes/pharmacology
  • Zebrafish
PubMed
37865998 Full text @ Biomed. Pharmacother.
Abstract
Terpenes are the most extensive and varied group of naturally occurring compounds mostly found in plants, including cannabis, and have an array of potential therapeutic benefits for pathological conditions. The endocannabinoid system can potently modulate anxiety in humans, rodents, and zebrafish. The 'entourage effect' suggests terpenes may target cannabinoid CB1 and CB2 receptors, among others, but this requires further investigation. In this study we first tested for anxiety-altering effects of the predominant 'Super-Class' terpenes, bisabolol (0.001%, 0.0015%, and 0.002%) and terpinolene (TPL; 0.01%, 0.05%, and 0.1%), in zebrafish with the open field test. Bisabolol did not have an effect on zebrafish behaviour or locomotion. However, TPL caused a significant increase in time spent in the inner zone and decrease in time spent in the outer zone of the arena indicating an anxiolytic (anxiety decreasing) effect. Next, we assessed whether CB1 and CB2 receptor antagonists, rimonabant and AM630 (6-Iodopravadoline) respectively, could eliminate or reduce the anxiolytic effects of TPL (0.1%) and β-caryophyllene (BCP; 4%), another super-class terpene previously shown to be anxiolytic in zebrafish. Rimonabant and AM630 were administered prior to terpene exposure and compared to controls and fish exposed to only the terpenes. AM630, but not rimonabant, eliminated the anxiolytic effects of both BCP and TPL. AM630 modulated locomotion on its own, which was potentiated by terpenes. These findings suggest the behavioural effects of TPL and BCP on zebrafish anxiety-like behaviour are mediated by a selective preference for CB2 receptor sites. Furthermore, the CB2 pathways mediating the anxiolytic response are likely different from those altering locomotion.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping